Crossref journal-article
American Chemical Society (ACS)
Journal of Medicinal Chemistry (316)
Bibliography

Seierstad, M., & Breitenbucher, J. G. (2008). Discovery and Development of Fatty Acid Amide Hydrolase (FAAH) Inhibitors. Journal of Medicinal Chemistry, 51(23), 7327–7343.

Authors 2
  1. Mark Seierstad (first)
  2. J. Guy Breitenbucher (additional)
References 136 Referenced 158
  1. {'key': 'ref1/cit1', 'first-page': '111', 'volume': '56', 'author': 'Lambert D. M.', 'year': '2001', 'journal-title': 'J. Pharm. Belg.'} / J. Pharm. Belg. by Lambert D. M. (2001)
  2. 10.1016/0040-4020(63)85022-X / Tetrahedron by Mechoulam R. (1963)
  3. 10.1021/ja01062a046 / J. Am. Chem. Soc. by Gaoni Y. (1964)
  4. 10.1038/346561a0 / Nature by Matsuda L. A. (1990)
  5. 10.1038/365061a0 / Nature by Munro S. (1993)
  6. 10.1080/02791072.1998.10399689 / J. Psychoact. Drugs by Calhoun S. R. (1998)
  7. 10.1111/j.1526-4637.2006.00085.x / Pain Med. by Berlach D. M. (2006)
  8. 10.1126/science.1470919 / Science by Devane W. A. (1992)
  9. 10.1016/0006-2952(95)00109-D / Biochem. Pharmacol. by Mechoulam R. (1995)
  10. 10.1126/science.1470919 / Science by Devane W. A. (1992)
  11. 10.1038/sj.bjp.0707456 / Br. J. Pharmacol. by Alexander S. P. H. (2007)
  12. 10.1016/S0021-9258(18)96775-X / J. Biol. Chem. by Bachur N. R. (1966)
  13. 10.1038/384083a0 / Nature by Cravatt B. F. (1996)
  14. 10.1074/jbc.M606646200 / J. Biol. Chem. by Wei B. Q. (2006)
  15. 10.1074/jbc.M413473200 / J. Biol. Chem. by Tsuboi K. (2005)
  16. 10.1021/jm058183t / J. Med. Chem. by Lambert D. M. (2005)
  17. 10.1038/sj.bjp.0707433 / Br. J. Pharmacol. by Jhaveri M. D. (2007)
  18. 10.1073/pnas.94.6.2238 / Proc. Natl. Acad. Sci. U.S.A. by Giang D. K. (1997)
  19. 10.1073/pnas.161191698 / Proc. Natl. Acad. Sci. U.S.A. by Cravatt B. F. (2001)
  20. 10.1073/pnas.96.21.12198 / Proc. Natl. Acad. Sci. U.S.A. by Walker J. M. (1999)
  21. 10.1097/00001756-200210280-00001 / NeuroReport by Fride E. (2002)
  22. 10.1523/JNEUROSCI.23-10-04127.2003 / J. Neurosci. by Veldhuis W. B. (2003)
  23. 10.1038/sj.bjp.0706755 / Br. J. Pharmacol. by Shouman B. (2006)
  24. 10.1016/j.pain.2004.01.022 / Pain by Lichtman A. H. (2004)
  25. 10.1172/JCI200419465 / J. Clin. Invest. by Massa F. (2004)
  26. 10.1073/pnas.0401292101 / Proc. Natl. Acad. Sci. U.S.A. by Cravatt B. F. (2004)
  27. 10.1126/science.1142265 / Science by Karsak M. (2007)
  28. 10.1093/sleep/27.5.857 / Sleep by Huitron-Resendiz S. (2004)
  29. 10.1038/sj.npp.1301224 / Neuropsychopharmacology by Varvel S. A. (2007)
  30. 10.1002/cmdc.200700168 / ChemMedChem by Lambert D. M. (2007)
  31. 10.1016/j.phrs.2007.09.002 / Pharmacol. Res. by Bisogno T. (2007)
  32. 10.1002/dmrr.764 / Diabetes Metab. Res. Rev. by Cota D. (2007)
  33. 10.1002/cbdv.200790157 / Chem. Biodiversity by Labar G. (2007)
  34. 10.1111/j.1471-4159.1984.tb12750.x / J. Neurochem. by Natarajan V. (1984)
  35. 10.1016/0006-2952(93)90486-G / Biochem. Pharmacol. by Deutsch D. G. (1993)
  36. 10.1016/S0167-4838(96)00145-8 / Biochim. Biophys. Acta by Chebrou H. (1996)
  37. 10.1073/pnas.94.22.11986 / Proc. Natl. Acad. Sci. U.S.A. by Kobayashi M. (1997)
  38. 10.1016/S1388-1981(99)00143-2 / Biochim. Biophys. Acta by Goparaju S. K. (1999)
  39. 10.1006/bbrc.1999.1524 / Biochem. Biophys. Res. Commun. by Omeir R. L. (1999)
  40. 10.1021/bi990637z / Biochemistry by Patricelli M. P. (1999)
  41. 10.1016/S0022-3565(24)37574-3 / J. Pharmacol. Exp. Ther. by Edgemond W. S. (1998)
  42. 10.1021/bi991876p / Biochemistry by Patricelli M. P. (1999)
  43. 10.1093/emboj/21.11.2509 / EMBO J. by Shin S. (2002)
  44. 10.1016/S0022-2836(02)00886-0 / J. Mol. Biol. by Labahn J. (2002)
  45. 10.1126/science.1076535 / Science by Bracey M. H. (2002)
  46. 10.1074/jbc.M001607200 / J. Biol. Chem. by Patricelli M. P. (2000)
  47. 10.1074/jbc.M604515200 / J. Biol. Chem. by Yun Y. S. (2006)
  48. 10.1039/b503887a / Chem. Commun. by Lodola A. (2005)
  49. 10.1021/ja065863s / J. Am. Chem. Soc. by Tubert-Brohman I. (2006)
  50. 10.1021/bi981733n / Biochemistry by Patricelli M. P. (1998)
  51. 10.1016/j.febslet.2004.04.084 / FEBS Lett. by Bracey M. H. (2004)
  52. 10.1074/jbc.M605653200 / J. Biol. Chem. by Mei G. (2007)
  53. 10.1016/S0006-2952(96)00830-1 / Biochem. Pharmacol. by Deutsch D. G. (1997)
  54. 10.1006/bbrc.1997.6000 / Biochem. Biophys. Res. Commun. by De Petrocellis L. (1997)
  55. 10.1006/bbrc.1997.6072 / Biochem. Biophys. Res. Commun. by Deutsch D. G. (1997)
  56. 10.1006/taap.2001.9342 / Toxicol. Appl. Pharmacol. by Quistad G. B. (2002)
  57. 10.1016/j.neuropharm.2006.11.009 / Neuropharmacology by Zhang D. (2007)
  58. 10.1038/nbt826 / Nat. Biotechnol. by Leung D. (2003)
  59. 10.1016/S0021-9258(17)31599-5 / J. Biol. Chem. by Koutek B. (1994)
  60. 10.1021/ja954064z / J. Am. Chem. Soc. by Patterson J. E. (1996)
  61. 10.1016/S0960-894X(00)00528-X / Bioorg. Med. Chem. Lett. by Boger D. L. (2000)
  62. 10.1016/0014-5793(95)01311-3 / FEBS Lett. by Maurelli S. (1995)
  63. 10.1021/ja055438j / J. Am. Chem. Soc. by Guimaraes C. R. W. (2005)
  64. 10.1016/S0960-894X(98)00734-3 / Bioorg. Med. Chem. Lett. by Boger D. L. (1999)
  65. 10.1006/bbrc.1998.8874 / Biochem. Biophys. Res. Commun. by Bisogno T. (1998)
  66. 10.1046/j.1432-1327.1999.00631.x / Eur. J. Biochem. by Di Marzo V. (1999)
  67. 10.1046/j.1471-4159.2000.0742597.x / J. Neurochem. by Jarrahian A. (2000)
  68. 10.1038/sj.bjp.0707145 / Br. J. Pharmacol. by Maione S. (2007)
  69. 10.1038/sj.bjp.0704199 / Br. J. Pharmacol. by Jonsson K.-O. (2001)
  70. 10.1124/jpet.300.3.984 / J. Pharmacol. Exp. Ther. by Di Marzo V. (2002)
  71. 10.1021/jm0209679 / J. Med. Chem. by Vandevoorde S. (2003)
  72. 10.1038/sj.bjp.0707326 / Br. J. Pharmacol. by Wallace V. C. J. (2007)
  73. 10.1073/pnas.97.10.5044 / Proc. Natl. Acad. Sci. U.S.A. by Boger D. L. (2000)
  74. 10.1016/S0960-894X(01)00211-6 / Bioorg. Med. Chem. Lett. by Boger D. L. (2001)
  75. 10.1016/j.bmc.2007.11.015 / Bioorg. Med. Chem. by Maryanoff B. E. (2008)
  76. 10.1021/ja00031a046 / J. Am. Chem. Soc. by Edwards P. D. (1992)
  77. 10.1124/jpet.104.069401 / J. Pharmacol. Exp. Ther. by Lichtman A. H. (2004)
  78. 10.1021/jm049614v / J. Med. Chem. by Boger D. L. (2005)
  79. 10.1016/j.bmcl.2004.12.085 / Bioorg. Med. Chem. Lett. by Leung D. (2005)
  80. 10.1038/sj.bjp.0706699 / Br. J. Pharmacol. by Chang L. (2006)
  81. 10.1021/ja064522b / J. Am. Chem. Soc. by Romero F. A. (2006)
  82. 10.1021/jm0611509 / J. Med. Chem. by Romero F. A. (2007)
  83. 10.1021/jm061414r / J. Med. Chem. by Hardouin C. (2007)
  84. Apodaca, R.; Breitenbucher, J. G.; Epperson, M. T.; Fried, A. K.; Pippel, D. J.; Seierstad, M.Preparation of Piperidinylbutanoyl Oxazoles as Fatty Acid Amide Hydrolase (FAAH) Modulators. WO 2007061862,2007.
  85. Apodaca, R.; Breitenbucher, J. G.; Chambers, A. L.; Seierstad, M.; Xiao, W.Preparation of Oxazolyl Piperidinyl Methanones As Modulators of Fatty Acid Amide Hydrolase. WO 2007140005,2007.
  86. 10.1021/jm011110z / J. Med. Chem. by Adang A. E. P. (2002)
  87. 10.1021/jm021119g / J. Med. Chem. by Tarzia G. (2003)
  88. 10.1021/jm031140x / J. Med. Chem. by Mor M. (2004)
  89. 10.1002/jms.729 / J. Mass Spectrom. by Basso E. (2004)
  90. 10.1016/j.chembiol.2005.08.011 / Chem. Biol. by Alexander J. P. (2005)
  91. 10.1038/nm803 / Nat. Med. by Kathuria S. (2003)
  92. 10.1124/jpet.104.078980 / J. Pharmacol. Exp. Ther. by Fegley D. (2005)
  93. 10.1038/sj.bjp.0706510 / Br. J. Pharmacol. by Jayamanne A. (2006)
  94. 10.1016/j.ejphar.2006.07.024 / Eur. J. Pharmacol. by Haller V. L. (2006)
  95. 10.1007/s00213-006-0689-4 / Psychopharmacology (Berlin) by Naidu P. S. (2007)
  96. Abouabdellah, A.; Bartsch-Li, R.; Hoornaert, C.; Ravet, A.Aryl- and Heteroaryl-alkylcarbamates Derivatives, Their Preparation, and Use as Fatty Acid Amido Hydrolase (FAAH) Inhibitors for Treating FAAH-Related Pathologies. WO 2005090292,2005.
  97. Abouabdellah, A.; Almario Garcia, A.; Hoornaert, C.; Li, A. T.Alkyl(homo)piperazine-carboxylate Derivatives, Their Preparation and Use as Fatty Acid Amido Hydrolase (FAAH) Inhibitors for Treating FAAH-Related Pathologies. WO 2005090322,2005.
  98. Abouabdellah, A.; Almario Garcia, A.; Hoornaert, C.; Lardenois, P.; Marguet, F.Aryl- and Heteroaryl-piperidinecarboxylate Derivatives, Their Preparation and Use as Fatty Acid Amido Hydrolase (FAAH) Inhibitors for Treating FAAH-Related Pathologies. WO 2005090347,2005.
  99. Abouabdellah, A.; Almario Garcia, A.; Froissant, J.; Hoornaert, C.Aryloxyalkylcarbamate Derivatives, Including Piperidine Carbamates, Their Preparation and Use as Fatty Acid Amido Hydrolase (FAAH) Inhibitors for Treating FAAH-Related Pathologies. WO 2005077898,2005.
  100. Abouabdellah, A.; Bas, M.; Dargazanli, G.; Hoornaert, C.; Li, A. T.; Medaisko, F.Dioxane-2-alkylcarbamates, Their Preparation and Use as Fatty Acid Amido Hydrolase (FAAH) Inhibitors for Treating FAAH-Related Pathologies. WO 2004020430,2004.
  101. Kennett, G. A.; Barratt, L.; Geoffroy, S.; Howes, R.In the Rat Formalin Paw Test, VER-154403, a FAAH Inhibitor, Is Anti-Nociceptive and Increases Peripheral and Central Levels of 2-Arachidonylglycerol. Presented at the 37th Annual Meeting of the Society for Neuroscience,2007.
  102. 10.1016/j.bmcl.2007.04.009 / Bioorg. Med. Chem. Lett. by Sit S. Y. (2007)
  103. Sit, S.Y.; Xie, K.Preparation of Bisarylimidazolyl Fatty Acid Amide Hydrolase Inhibitors for Treatment of Pain. WO 2002087569,2002.
  104. Sit, S.Y.; Xie, K.; Deng, H.Preparation of (Hetero)aryl Carbamates and Oximes as Fatty Acid Amide Hydrolase Inhibitors. WO 2003065989,2003.
  105. Sit, S.Y.Presented at National Organic Symposium, Salt Lake City, UT,2005.
  106. 10.1021/jm070501w / J. Med. Chem. by Myllymaki M. J. (2007)
  107. Ishii, T.; Sugane, T.; Maeda, J.; Narazaki, F.; Kakefuda, A.; Sato, K.; Takahashi, T.; Kanayama, T.; Saitoh, C.; Suzuki, J.; Kanai, C.Preparation of Pyridyl Non-Aromatic Nitrogenated Heterocyclic-1-Carboxylate Ester Derivatives as FAAH Inhibitors. WO 2006088075,2006.
  108. Dasse, O.; Putman, D.; Compton, T. R.; Parrott, J.Alkylcarbamic Acid Ester Inhibitors of Fatty Acid Amide Hydrolase, and Therapeutic Use. WO 2007079180,2007.
  109. 10.1007/s10571-006-9072-6 / Cell. Mol. Neurobiol. by Dickason-Chesterfield A. K. (2006)
  110. 10.1021/ja062999h / J. Am. Chem. Soc. by Alexander J. P. (2006)
  111. Matsumoto, T.; Kori, M.; Miyazaki, J.; Kiyota, Y.Preparation of Piperidinecarboxamides and Piperazinecarboxamides as Fatty Acid Amide Hydrolase (FAAH) Inhibitors. WO 2006054652,2006.
  112. Matsumoto, T.; Kori, M.; Kouno, M.Preparation of Piperazine-1-carboxamide derivatives as Brain/Neuronal Cell-Protecting Agents, and Therapeutic Agents for Sleep Disorder. WO 2007020888,2007.
  113. Apodaca, R.; Breitenbucher, J. G.; Pattabiraman, K.; Seierstad, M.; Xiao, W.Preparation of Thiadiazolylpiperazinecarboxamides as Modulators of Fatty Acid Amide Hydrolase (FAAH).,2007.
  114. {'volume-title': 'Nociception: Taking the Pain out of Drug Discovery', 'year': '2006', 'author': 'Breitenbucher J. G.', 'key': 'ref114/cit114'} / Nociception: Taking the Pain out of Drug Discovery by Breitenbucher J. G. (2006)
  115. Apodaca, R.; Breitenbucher, J. G.; Pattabiraman, K.; Seierstad, M.; Xiao, W.Piperazinyl and Piperidinyl Ureas as Modulators of Fatty Acid Amide Hydrolase. WO 2006074025,2006.
  116. 10.1021/bi701378g / Biochemistry by Ahn K. (2007)
  117. 10.1007/BF00421212 / Psychopharmacologia by Torii S. (1973)
  118. 10.1016/S0960-894X(98)00073-0 / Bioorg. Med. Chem. Lett. by Patricelli M. P. (1998)
  119. 10.1016/S0014-5793(97)00061-6 / FEBS Lett. by Beltramo M. (1997)
  120. Bartolini, W.; Cali, B. M.; Chen, B.; Chien, Y.T.; Currie, M. G.; Milne, T. G.; Pearson, J. P.; Talley, J. J.; Zimmerman, C.COX-2 and FAAH Inhibitors. WO 2005002525,2005.
  121. Bartolini, W.; Cali, B. M.; Chen, B.; Chen, Y. T.; Currie, M. G.; Milne, G.T.; Pearson, J. P.; Talley, J. J.; Yang, J. J.; Zimmerman, C.Modulators of CRTH2, COX-2 and FAAH. WO 2006036994,2006.
  122. 10.1021/jm060394q / J. Med. Chem. by Saario S. M. (2006)
  123. 10.1021/jm050977k / J. Med. Chem. by Muccioli G. G. (2006)
  124. 10.1016/j.bmcl.2006.06.087 / Bioorg. Med. Chem. Lett. by Michaux C. (2006)
  125. 10.1038/sj.bjp.0705334 / Br. J. Pharmacol. by Patel S. (2003)
  126. 10.1097/00000542-200602000-00012 / Anesthesiology by Schelling G. (2006)
  127. 10.1038/sj.bjp.0704113 / Br. J. Pharmacol. by Holt S. (2001)
  128. 10.1074/jbc.M501489200 / J. Biol. Chem. by Hogestatt E. D. (2005)
  129. 10.1073/pnas.0806121105 / Proc. Natl. Acad. Sci. U.S.A. by Mileni M. (2008)
  130. 10.1021/jm701210y / J. Med. Chem. by Kimball F. S. (2008)
  131. 10.1021/jm800136b / J. Med. Chem. by Garfunkle J. (2008)
  132. 10.1016/j.bmcl.2008.01.091 / Bioorg. Med. Chem. Lett. by Timmons A. (2008)
  133. 10.1021/jm701631z / J. Med. Chem. by Mor M. (2008)
  134. 10.1016/j.bmcl.2008.07.081 / Bioorg. Med. Chem. Lett. by Keith J. M. (2008)
  135. 10.1016/j.bmcl.2008.05.081 / Bioorg. Med. Chem. Lett. by Urbach A. (2008)
  136. Adams, J.; Behnke, M. L.; Castro, A. C.; Evans, C. A.; Grenier, L.; Grogan, M. J.; Liu, T.; Snyder, D. A.; Tibbitts, T. T.Inhibitors of Fatty Acid Amide HydrolaseWO 2008063300,2008.
Dates
Type When
Created 16 years, 9 months ago (Nov. 5, 2008, 6 a.m.)
Deposited 6 months, 3 weeks ago (Feb. 2, 2025, 9:12 a.m.)
Indexed 1 month ago (July 26, 2025, 5:03 a.m.)
Issued 16 years, 9 months ago (Nov. 5, 2008)
Published 16 years, 9 months ago (Nov. 5, 2008)
Published Online 16 years, 9 months ago (Nov. 5, 2008)
Published Print 16 years, 8 months ago (Dec. 11, 2008)
Funders 0

None

@article{Seierstad_2008, title={Discovery and Development of Fatty Acid Amide Hydrolase (FAAH) Inhibitors}, volume={51}, ISSN={1520-4804}, url={http://dx.doi.org/10.1021/jm800311k}, DOI={10.1021/jm800311k}, number={23}, journal={Journal of Medicinal Chemistry}, publisher={American Chemical Society (ACS)}, author={Seierstad, Mark and Breitenbucher, J. Guy}, year={2008}, month=nov, pages={7327–7343} }